Similarly, in an in vitro model of NAFLD, TSP-1 expression by hepatocytes upon free fatty acid treatment, was associated with fat accumulation, inflammation and fibrogenesis (286). Here, THBS1 is linked to metabolic dysfunction-associated steatotic liver disease.